Rare Disease Access at Risk: What Biopharma Leaders Need to Know About the 2025 Medicaid Overhaul
December 17, 2025
By: Sam Rieger, Yakir Siegal, Pamela Engelhart
Rare Disease Access at Risk: What Biopharma Leaders Need to Know About the 2025 Medicaid Overhaul Medicaid, covering...
Continue Reading
Danforth Health Acquires Asymmetry Group to Expand Life Science Commercialization Support
October 22, 2025
By: Gregory Lief
Today marks a major inflection point for Asymmetry Group, LLC as we join Danforth Health in our common...
Continue Reading
Asymmetry Group, LLC Ranks No. 4373 on the 2025 Inc. 5000 List
August 12, 2025
By: Gregory Lief
Asymmetry Group, LLC Ranks No. 4,373 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies With...
Continue Reading
Reflections on BIO International Convention 2025
July 1, 2025
By: Yakir Siegal, Greg Lief, Aditi Doshi, Jeanelle Ackerman, Jenna Charles Carson and Aditi Dubey
Members of the Asymmetry Group team recently attended the BIO International Convention in Boston, a conference that brought...
Continue Reading
Recognizing Alzheimer’s & Brain Awareness Month
June 27, 2025
By: Yakir Siegal, Greg Lief and Nolan Webb
Alzheimer’s and Brain Awareness month is dedicated to raising awareness about Alzheimer’s disease, other forms of dementia, and...
Continue Reading
Asymmetry Group, LLC Named to Inc.’s 2025 Best Workplaces List
June 17, 2025
By: Greg Lief
NEW YORK, June 17, 2025 – Asymmetry Group, LLC is proud to announce it has been named...
Continue Reading
Evolution v. Revolution: The Impact of ‘Most Favored Nation’ Pricing
May 23, 2025
By: Annie Scolamieri, Aditi Doshi, Pamela Engelhart, Gregory Lief, and Yakir Siegal
The past few months have been marked by a flurry of announcements and sweeping policy proposals from the...
Continue Reading
Recognizing Mental Health Awareness Month
May 16, 2025
By: Courtney McGee, Nolan Webb, Gregory Lief, and Yakir Siegal
May marks Mental Health Awareness Month, a time dedicated to supporting mental well-being while promoting advocacy, policy, and...
Continue Reading
Better Decisions, Stronger Teams: The Power of Breaking Down Bias
April 2, 2025
By: Aditi Doshi
Unconscious bias is a natural byproduct of how our brains process the world. But just because it’s natural...
Continue Reading
The Future of Biopharma: Reflections on MassBio’s State of Possible 2025 Conference
March 28, 2025
By: Gregory Lief, Yakir Siegal, and Vivian Chen
Three weeks ago, we shared our perspective on the national trends and policies creating swirl in the biopharma...
Continue Reading
Reflections on the Simmons Leadership Conference 2025
March 27, 2025
By: Rachel Sachs, Courtney McGee, Nellie Stidham, Jenna Charles Carson, Aditi Doshi, and Michael Nguyen
Last week, six of our Asymmetry team members attended the Simmons Leadership Conference, an empowering one-day event hosted...
Continue Reading
Addressing Rare Disease Care Pathways
February 26, 2025
By: Aditi Doshi, Pamela Engelhart, Annie Scolamieri, Gregory Lief, and Yakir Siegal
Addressing Rare Disease Care Pathways It’s no secret that we’ve seen incredible innovation in effective treatments for rare...
Continue Reading
Navigating Policy Whiplash: Implications for Biopharma
February 18, 2025
By: Pamela Engelhart, Aditi Doshi, Annie Scolamieri, Yakir Siegal, and Gregory Lief
Navigating Policy Whiplash: Implications for Biopharma The waves are picking up, the surf is churning, and clarity on...
Continue Reading